Fetal Hemoglobin in Bone Marrow Failure Syndromes: Comparative Utility Versus PNH Clones and Telomere Length
Victoria Heigh(Mayo Clinic), Abhishek A. Mangaonkar(Mayo Clinic), Aref Al‐Kali(Mayo Clinic), M. Hefazi(Mayo Clinic), Maymona Abdelmagid(Mayo Clinic), Mithun Vinod Shah(Mayo Clinic in Arizona), Ahmad Al‐Huniti(Mayo Clinic), Aasiya Matin(Mayo Clinic in Arizona), Mira A. Kohorst(Mayo Clinic), Yael Kusne(WinnMed), Naseema Gangat(Mayo Clinic in Arizona), Alejandro Ferrer(Mayo Clinic), William J. Hogan(Mayo Clinic), Laura Ongie(Mayo Clinic), Xi Zhang(Mayo Clinic), Anand Srinivasan(Mayo Clinic), James Foran(Mayo Clinic in Arizona), Hassan B. Alkhateeb(Mayo Clinic), Mrinal M. Patnaik(Mayo Clinic), Terra L. Lasho(Mayo Clinic)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2016|297